Komori
Mani (7730) · InitiativeAdvanced

Construction of a New Vietnam Plant to Accommodate Future Order Growth

First written in FY2016-Q3. 13 of 19 entries say "Advanced", first in FY2016. Latest entry: 2026-10-15.

19entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q3AdvancedFY2023 – 2026-10-152016: 220162017: 420172018: 420182019: 320192020: 020202021: 020212022: 020222023: 120232024: 220242025: 120252026: 22026
Same theme, other companies
Increasing capacity to meet orders through construction of a new factory in VietnamA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. 2026-10-15AdvancedEarnings

    「スマートファクトリーでの量産を2026年9月から開始」

    JIZAIの量産が花岡スマートファクトリーで開始される段階に進んでいる。
  2. FY2026-H1AdvancedAnnual report

    「In light of growing market demand for JIZAI, the company has decided to prioritize the product and begin mass production at the Hanaoka Plant in September 2026, in the fiscal year ending August 2027.」

    For the Hanaoka Smart Factory, following completion in January 2025, the company has progressed to the decision to prioritize JIZAI and begin mass production in September 2026.
  3. FY2025-H1AdvancedAnnual report

    「Construction of the Hanaoka Plant in Japan began in October 2023 and was completed at the end of January 2025. During the interim consolidated accounting period, the company proceeded with establishing a production structure for ophthalmic knives and the NiTi rotary file JIZAI with a view to beginning mass production in 2026.」

    Regarding efforts to expand production capacity in preparation for future growth in orders, the company reports completion of the Hanaoka Smart Factory and the establishment of a production structure with a view to beginning mass production in 2026.
  4. FY2024AdvancedAnnual report

    「The smart factory now under construction is positioned as a pilot plant for establishing mass-production technology for new products and next-generation automated production lines for major existing products, with a view to subsequent overseas deployment. While reducing labor requirements in manufacturing and lowering product costs, the company aims to expand sales globally. In particular, preparations are under way to establish a mass-production structure for JIZAI, a NiTi rotary file used in dental root canal treatment and a key development product, and ophthalmic knives used in cataract surgery and other procedures.」

    The company is advancing a plan to develop the smart factory as a pilot plant for mass production of JIZAI and ophthalmic knives and for automated production lines, with total investment of ¥10.5 billion and scheduled completion in January 2025.
  5. FY2024-Q1AdvancedAnnual report

    「The company will expand its existing plant in Vietnam to increase production capacity and strengthen business continuity planning (BCP).」

    In addition to construction of the previous new plant and the seventh-phase plant, the company explicitly identifies expansion of its existing plant in Vietnam as a means of increasing production capacity and strengthening BCP.
  6. FY2023AdvancedAnnual report

    「To establish a further expanded production structure, the company will proceed with construction of the seventh-phase plant.」

    Following the new plant in Vietnam and the Phu Yen No. 2 plant, the company reports a plan to further expand its production structure by proceeding with construction of the seventh-phase plant.
  7. FY2019-Q3RestatedAnnual report

    「As production of Ales needles following the start-up of the Phu Yen No. 2 plant gained traction, among other factors, segment profit (operating profit) was ¥1,784 million, up 4.1% year on year.」

    The start-up of the Phu Yen No. 2 plant and the establishment of stable Ales needle production continued to be reflected in results.
  8. FY2019-Q2AdvancedAnnual report

    「As sales to major overseas customers remained strong following the establishment of an expanded production structure at the Phu Yen No. 2 plant, revenue was ¥3,017 million, up 12.0% year on year. In addition to higher revenue, increased production of Ales needles following the start-up of the Phu Yen No. 2 plant gained traction, among other factors, and segment profit (operating profit) was ¥1,213 million, up 19.3% year on year.」

    The establishment and start-up of an expanded production structure at the Phu Yen No. 2 plant enabled increased production of Ales needles to gain traction, contributing to a 12.0% increase in revenue and a 19.3% increase in segment profit.
  9. FY2019-Q1AdvancedAnnual report

    「As sales of Ales needles remained strong overseas, revenue was ¥1,568 million, up 34.4% year on year. In addition to higher revenue, increased production of Ales needles following the start-up of the new plant in Vietnam gained traction, among other factors, and segment profit (operating profit) was ¥634 million, up 67.7% year on year.」

    Increased production of Ales needles following the start-up of the new plant in Vietnam gained traction, contributing to a 34.4% increase in revenue from the product and a 67.7% increase in segment profit.
  10. FY2018AdvancedAnnual report

    「As increased production of Ales suture needles following the start-up of the new plant in Vietnam gained traction, segment profit (operating profit) was ¥2,260 million, up 43.3% year on year.」

    The company reports that, following the start-up of the new plant, increased production of Ales suture needles gained traction and contributed to higher segment profit.
  11. FY2018-Q3AdvancedAnnual report

    「As production expansion at the new plant in Vietnam proceeded and sales to Europe and Asia remained strong, revenue was ¥4,392 million, up 36.0% year on year.」

    Following the expansion of production at the new plant, the company reports strong sales to Europe and Asia and a 36.0% increase in revenue from Ales needle-related products, indicating that expanded production after completion of construction has begun to contribute to results.
  12. FY2018-Q2AdvancedAnnual report

    「The company continued preparations to increase production at the new plant to accommodate growth in orders for Ales needles.」

    For the new plant, where preparations for start-up had been under way following completion of construction, the company reports that efforts have progressed to the stage of increasing production to accommodate growth in orders for Ales needles.
  13. FY2018-Q1RestatedAnnual report

    「The company continued preparations for the full-scale operation of the new plant to accommodate future growth in orders.」

    For the new plant in Vietnam following completion of construction, preparations for full-scale operation are continuing. No new milestone such as the completion of start-up is reported.
  14. FY2017RestatedAnnual report

    「To accommodate future growth in orders, construction of the new plant was completed and preparations for start-up were advanced.」

    The company reconfirms that, following completion of the new plant, preparations for start-up are under way. Construction completion itself was also reported in the previous quarter.
  15. FY2017-Q3AdvancedAnnual report

    「To accommodate future growth in orders, construction of the new plant was completed and preparations for start-up were advanced.」

    The new plant in Vietnam reached the concrete milestone of construction completion, and the company moved on to preparations for start-up.
  16. FY2017-Q2RestatedAnnual report

    「The company continued to prepare for the construction and start-up of a new plant to accommodate future growth in orders.」

    For the new plant in Vietnam, construction and preparations for start-up are continuing, but no new milestone such as completion or commencement of operations is reported.
  17. FY2017-Q1RestatedAnnual report

    「To accommodate future growth in orders, the company continued from the previous consolidated fiscal year to prepare for the construction and start-up of the new plant.」

    For the new plant in Vietnam, the company states that construction and preparations for start-up are continuing from the previous fiscal year, but does not present any new milestone such as completion.
  18. FY2016AdvancedAnnual report

    「MANI HANOI CO., LTD. plant building: planned investment ¥2,340 million; amount paid to date ¥665 million; construction started December 2015; completion November 2016; production area 29,000㎡」

    For the new plant in Vietnam, the company disclosed the investment amount, amount paid to date, scheduled completion date and production area, indicating concrete progress in construction.
  19. FY2016-Q3First statedAnnual report

    「We have also begun construction of a new plant to accommodate future growth in orders.」

    Reports concrete progress, namely the start of construction of a new plant to accommodate future order growth.
Moved together

"Local Marketing and Sales Network Development Focused on China and Vietnam" moved the same way as this thread, in the same document, in 8 of its 19 moves.

888555★123456
  1. ★This thread
  2. 1Local Marketing and Sales Network Development Focused on China and Vietnam8×
  3. 2Delays in Reorganizing the Chinese Sales Network and Weak Sales in Emerging Markets8×
  4. 3Developing and Launching New Products for Advanced Markets8×
  5. 4Expanding Sales in Advanced Markets5×
  6. 5R&D of Core Medical and Dental Products and Foundational Technologies5×
  7. 6Acquisition of Land for the Expansion of Headquarters and Domestic Plant Facilities5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Mani's next results are scheduled for 2026-10-15. Read the earnings preview It last moved in the Earnings of 2026-10-15: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.